Literature DB >> 6133847

The prognosis of tardive dyskinesia.

G Gardos, J O Cole.   

Abstract

Reexamination of the prognosis of tardive dyskinesia indicates that the concept of irreversibility should be replaced by a focus on longitudinal changes. Factors involved in the etiology and point prevalence of TD (e.g., neuroleptic exposure) are not necessarily the determinants of outcome. The presence of affective disorder and poor response to treatment in chronic psychotic patients appear to be related to poor prognosis. Severe dyskinesia with functional impairment is rare. Such severe cases are more likely to show a rapidly developing malignant course than to be the end result of slowly progressing TD after many years of neuroleptic treatment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6133847

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  3 in total

1.  A case of dramatic improvement of severe tardive dyskinesia after switch to aripiprazole.

Authors:  Hannah E Brown; Alice W Flaherty; Donald C Goff; Oliver Freudenreich
Journal:  Prim Care Companion CNS Disord       Date:  2011

2.  Resveratrol Protects Against Vacuous Chewing Movements Induced by Chronic Treatment with Fluphenazine.

Authors:  Alcindo Busanello; Caroline Queiroz Leal; Luis Ricardo Peroza; Jivago Röpke; Elizete de Moraes Reis; Catiuscia Molz de Freitas; Milena Libardoni; Nilda Berenice de Vargas Barbosa; Roselei Fachinetto
Journal:  Neurochem Res       Date:  2017-07-25       Impact factor: 3.996

3.  Dose-dependent differences in the development of reserpine-induced oral dyskinesia in rats: support for a model of tardive dyskinesia.

Authors:  J L Neisewander; E Castañeda; D A Davis
Journal:  Psychopharmacology (Berl)       Date:  1994-09       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.